Prostate Cancer - Results from #22140

Biochemical and objective response to abiraterone acetate withdrawal: Incidence and clinical relevance of a new scenario for castration-resistant prostate cancer - Abstract October 8, 2013

Co-existent Paget's disease of the bone, prostate carcinoma skeletal metastases and fracture on skeletal scintigraphy-lessons to be learned - Abstract October 8, 2013

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer - Abstract October 8, 2013

Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era - Abstract October 8, 2013

3D prostate histology reconstruction: An evaluation of image-based and fiducial-based algorithms - Abstract October 8, 2013

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: Interim analysis of acute toxicity and quality of life in 124 patients - Abstract October 8, 2013

Complementary and alternative medicine (CAM) in prostate and bladder cancer - Abstract October 8, 2013

Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells - Abstract October 7, 2013

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer - Abstract October 7, 2013

Androgens and prostate cancer; pathogenesis and deprivation therapy - Abstract October 7, 2013

Epigenetic susceptibility factors for prostate cancer with aging - Abstract October 7, 2013

Prostate cancer detection and diagnosis: The role of MR and its comparison with other diagnostic modalities - A radiologist's perspective - Abstract October 7, 2013

Results of radical prostatectomy in newly diagnosed prostate cancer: Long-term survival rates in locally advanced and high-risk cancers - Abstract October 7, 2013

Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer - Abstract October 7, 2013

Evaluation of image-guidance strategies for prostate cancer - Abstract October 7, 2013

11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: Preliminary results of tolerability and acute toxicity - Abstract October 7, 2013

Overtreatment of prostate cancer may be prevented by extended pelvic lymphadenectomy - Abstract October 7, 2013

Leading robotic prostate cancer surgeon and researcher to head Mount Sinai’s urology department October 7, 2013

PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy - Abstract October 4, 2013

Retrospective analysis of predicting biochemical recurrence after initial radical prostatectomy - Abstract October 4, 2013

Page 1108 of 1437